Real-time enrollment status for this i cannot determine the primary medical condition from the provided information. the study title only mentions it's a "rollover study for continued access" for ribociclib (lee011), and the conditions listed are just the drug names. the brief summary appears to be incomplete (showing only "localhost:3000/trial/"). without additional clinical context about what condition ribociclib treats, i cannot extract the patient-facing medical condition. clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 8:49 AM UTC
| NCT Number | NCT02934568 |
| Recruiting Status | Active, Not Recruiting |
| Condition | I cannot determine the primary medical condition from the provided information. The study title only mentions it's a "rollover study for continued access" for Ribociclib (LEE011), and the conditions listed are just the drug names. The brief summary appears to be incomplete (showing only "localhost:3000/trial/"). Without additional clinical context about what condition Ribociclib treats, I cannot extract the patient-facing medical condition. |
| Phase | Clinical Trial |
| Target Enrollment | 50 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | February 12, 2026 (2 weeks ago) |
As of March 2, 2026: Clinical trial NCT02934568 is currently active_not_recruiting participants. This clinical trial study for i cannot determine the primary medical condition from the provided information. the study title only mentions it's a "rollover study for continued access" for ribociclib (lee011), and the conditions listed are just the drug names. the brief summary appears to be incomplete (showing only "localhost:3000/trial/"). without additional clinical context about what condition ribociclib treats, i cannot extract the patient-facing medical condition. is not currently accepting new participants at 5 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT02934568 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02934568 was last updated 2 weeks ago (February 12, 2026). HelloStudys verifies this status automatically.